000 | 01996 a2200589 4500 | ||
---|---|---|---|
005 | 20250517042816.0 | ||
264 | 0 | _c20160420 | |
008 | 201604s 0 0 eng d | ||
022 | _a2047-9980 | ||
024 | 7 |
_a10.1161/JAHA.115.001921 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAn, JaeJin | |
245 | 0 | 0 |
_aStroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. _h[electronic resource] |
260 |
_bJournal of the American Heart Association _cJul 2015 |
||
500 | _aPublication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAspirin _xadverse effects |
650 | 0 | 4 |
_aAtrial Fibrillation _xblood |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 |
_aCalifornia _xepidemiology |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
650 | 0 | 4 | _aHealth Maintenance Organizations |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStroke _xblood |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWarfarin _xadverse effects |
700 | 1 | _aNiu, Fang | |
700 | 1 | _aLang, Daniel T | |
700 | 1 | _aJazdzewski, Kristin P | |
700 | 1 | _aLe, Paul T | |
700 | 1 | _aRashid, Nazia | |
700 | 1 | _aMeissner, Brian | |
700 | 1 | _aMendes, Robert | |
700 | 1 | _aDills, Diana G | |
700 | 1 | _aAranda, Gustavus | |
700 | 1 | _aBruno, Amanda | |
773 | 0 |
_tJournal of the American Heart Association _gvol. 4 _gno. 7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/JAHA.115.001921 _zAvailable from publisher's website |
999 |
_c25087006 _d25087006 |